share_log

Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares

Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares

凯西·伍德的方舟投资继续在Moderna上加倍下注,出售英伟达股票
Benzinga ·  03/26 22:30

On Tuesday, Cathie Wood's Ark Invest made a significant move by increasing its stake in Moderna Inc. (NASDAQ:MRNA), a leading COVID-19 vaccine maker. This move comes amidst a series of upcoming catalysts for the biotech firm.

周二,凯西·伍德旗下的方舟投资采取了重大举措,增加了其在领先的 COVID-19 疫苗生产商摩德纳公司(纳斯达克股票代码:MRNA)的股份。此举是在这家生物技术公司即将推出的一系列催化剂之际采取的。

The MRNA Trade

MRNA 交易

Ark Invest, through its flagship Ark Innovation ETF (NYSE:ARKK), purchased a whopping 72,800 shares of Moderna. Based on the closing price of $107.41 on the same day, the value of this trade stands at approximately $7.82 million. This move indicates a strong belief in the biotech firm's potential, as Ark Invest has been consistently increasing its holdings in Moderna throughout March.

方舟投资通过其旗舰方舟创新ETF(纽约证券交易所代码:ARKK)购买了高达72,800股Moderna的股票。根据当天107.41美元的收盘价,该交易的价值约为782万美元。此举表明人们坚信这家生物技术公司的潜力,因为方舟投资在整个三月份一直在增加其在Moderna的持股。

The buying spree reflected Ark's confidence in Moderna's diversified pipeline beyond its mRNA COVID-19 vaccine, including a next-gen COVID-19 vaccine and other promising candidates. With expectations of vaccine approvals and upcoming investor events, Ark appears to be anticipating further growth potential despite Moderna's recent market performance.

此次收购狂潮反映了方舟对Moderna除mRNA COVID-19 疫苗之外的多元化产品线的信心,包括下一代 COVID-19 疫苗和其他有前途的候选疫苗。尽管Moderna最近表现出色,但由于对疫苗批准和即将举行的投资者活动的预期,Ark似乎预计会有进一步的增长潜力。

Over 12 months Moderna stock has declined 26.89%, however, since 2024 started the stock has gained 8%.

在过去的12个月中,Moderna的股票下跌了26.89%,但是,自2024年开始以来,该股已经上涨了8%。

Other Key Trades:

其他关键交易:

  • The ARKG fund sold 1,770 shares of Nvidia Corp (NASDAQ:NVDA). That trade, made through ARK Genomic Revolution ETF (NYSE:ARKG), was valued at $1.63 million.
  • Ark Invest's ARKF fund bought shares of Roblox Corp (NYSE:RBLX).
  • ARKG also bought shares of Recursion Pharmaceuticals (NASDAQ:RXRX). ARKK purchased 60,9626 shares of Recursion Pharmaceuticals. ARKQ sold shares of Trimble Inc (NASDAQ:TRMB).
  • ARKG基金出售了英伟达公司(纳斯达克股票代码:NVDA)的1,770股股票。这笔交易是通过方舟基因革命ETF(纽约证券交易所代码:ARKG)进行的,价值163万美元。
  • 方舟投资的ARKF基金购买了Roblox公司(纽约证券交易所代码:RBLX)的股票。
  • ARKG还购买了Recursion Pharmicals(纳斯达克股票代码:RXRX)的股票。ARKK购买了Recursion Pharmicals的60,9626股股票。ARKQ出售了天宝公司(纳斯达克股票代码:TRMB)的股票。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发